Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Retained Earnings (2023 - 2025)

Xenetic Biosciences' Retained Earnings history spans 6 years, with the latest figure at $253734.0 for Q4 2025.

  • For Q4 2025, Retained Earnings changed 0.0% year-over-year to $253734.0; the TTM value through Dec 2025 reached $253734.0, changed 0.0%, while the annual FY2025 figure was $253734.0, 0.0% changed from the prior year.
  • Retained Earnings reached $253734.0 in Q4 2025 per XBIO's latest filing, up from -$199.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $253734.0 in Q3 2023 to a low of -$199.3 million in Q3 2025.
  • Average Retained Earnings over 3 years is -$113.4 million, with a median of -$190.5 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: soared 100.13% in 2024, then crashed 78645.35% in 2025.
  • A 3-year view of Retained Earnings shows it stood at -$193.2 million in 2023, then soared by 100.13% to $253734.0 in 2024, then changed by 0.0% to $253734.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Retained Earnings are $253734.0 (Q4 2025), -$199.3 million (Q3 2025), and -$198.8 million (Q2 2025).